Helmut Schütz - Concepedia

Author

Helmut Schütz

Novartis (Switzerland)ORCID

Also Known As

H Schütz, H. Schutz, H. Schütz, H. SchÜtz, H. Schütz, Helmut Schütz

Publications

671

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Paul Scherrer Institute SBA Research University of Geneva

About

Helmut Schütz is an author at Novartis (Switzerland) specializing in medicine, drug analysis, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	246
2	Engineering	3	3	66
3	Health Sciences	1	1	149
4	Natural Sciences	1	1	13
5	Public Health	1	1	19

Helmut Schütz

Publications

579

Citations

H-Index

Page 1

	Year	Citations
The metabolism of<sup>14</sup>C-oxcarbazepine in man Helmut Schütz, K. F. Feldmann, J. W. Faigle, Xenobiotica Molecular PharmacologyGp 47,779Faecal ExcretionHealth SciencesPharmacological Study	1986	149
Continuous-relief diffractive optical elements for two-dimensional array generation Michael T. Gale, Markus Rossi, Helmut Schütz, Applied Optics	1993	76
DBR waveguide laser in erbium-diffusion-doped LiNbO <sub>3</sub> J. Söchtig, Rudolf Groß, Ingo Baumann, Electronics Letters	1995	47
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs Fanny De Jaeghere, Éric Allémann, Éric Doelker, AAPS PharmSci	2001	45
Fabrication of kinoform structures for optical computing M. T. Gale, G. K. Lang, Jeffrey M. Raynor, Applied Optics PhotonicsOptical MaterialsEngineeringMicrofabricationLaser Micro-processing	1992	37
Rapid high-performance liquid chromatographic determination of nifedipine in plasma with on-line precolumn solid-phase extraction Veit Nitsche, Helmut Schütz, A. Eichinger Journal of Chromatography B Biomedical Sciences and Applications BiochemistrySeparation ScienceMedicineGas ChromatographyMass Spectrometry	1987	28
Sample size determination in bioequivalence studies using statistical assurance Arne Ring, Benjamin Lang, C. Kazaroho, British Journal of Clinical Pharmacology	2019	28
Pharmacokinetic modelling and validation of the half‐life extension needed to reduce the burden of infusions compared with standard factor <scp>VIII</scp> Cédric Hermans, Johnny Mahlangu, J. Booth, Haemophilia	2018	21
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its Control Detlew Labes, Helmut Schütz Pharmaceutical Research Scaling AnalysisMeasurementScaled Average BioequivalenceBiostatisticsStatistical Averaging	2016	19
Distribution, kinetics and elimination of radioactivity after intravenous and intramuscular injection of 14C-savoxepine loaded poly(D,L-lactic acid) nanospheres to rats Éric Allémann, Robert Gurny, Éric Doelker, Journal of Controlled Release NanomedicinePharmaceutical SciencePolymer-drug Conjugate14C-savoxepine Loaded PolyMedicine	1994	17

Page 1